Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice

Shigehisa Yanagi1, Hiroyuki Kishimoto, Kohichi Kawahara

  • 1Department of Molecular Biology, Akita University School of Medicine, Akita, Japan.

Insights

Loss of the PTEN tumor suppressor gene in mice causes lung cancer. PTEN is crucial for normal lung development and preventing lung adenocarcinoma by maintaining bronchioalveolar stem cell homeostasis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The PTEN gene is a critical tumor suppressor frequently mutated in human cancers.
  • Understanding PTEN's role in lung carcinogenesis is vital for developing targeted therapies.

Purpose of the Study:

  • To investigate the function of PTEN in lung development and tumorigenesis using a mouse model.
  • To elucidate the molecular mechanisms by which PTEN loss contributes to lung adenocarcinoma.

Main Methods:

  • Generation of a doxycycline-inducible, bronchioalveolar epithelium-specific Pten null mutation in mice (SOPten(flox/flox)).
  • Administration of doxycycline in utero or postnatally to induce Pten deletion.
  • Histological, biochemical, and genetic analyses of lung tissues, including assessment of bronchioalveolar stem cells (BASCs) and oncogenic signaling pathways.

Main Results:

  • Conditional Pten deletion in mouse lungs led to hyperplasia, impaired surfactant production, and spontaneous lung adenocarcinomas.
  • Increased numbers of bronchioalveolar stem cells (BASCs) and elevated expression of Spry2, Akt, c-Myc, Bcl-2, and Shh were observed.
  • Urethane treatment accelerated tumor development, and K-ras mutations were frequent in induced lung adenocarcinomas.

Conclusions:

  • PTEN is essential for normal lung morphogenesis and acts as a crucial suppressor of lung carcinogenesis.
  • PTEN's tumor-suppressive function in the lung is likely mediated through the regulation of BASC homeostasis and key signaling pathways.

Related Concept Videos